A 17-year-old woman had a sudden eruption of pustules in her intertriginous areas as well as of erythematosquamous plaques on the scalp, elbows, palms and soles in the third trimester of her first pregnancy. Histopathological evaluation of a biopsy revealed typical changes of pustular psoriasis with parakeratosis and abscesses of neutrophils (Kogoj’s spongiform pustules). The diagnosis of pustular psoriasis was established by the typical clinical and histopathological findings. Laboratory parameters showed a highly elevated blood sedimentation rate, hypoferric anemia and decreased albumin levels. Serum concentrations of parathormone and its metabolites were normal. After systemic treatment with glucocorticosteroids and antibiotics, the lesions improved but did not clear. After delivery of a healthy boy, therapy was switched to retinoid photochemotherapy with isotretinoin and PUVA that resulted in rapid and complete clearing of the eruption. The coincidence of plaque-type psoriasis and a pustular eruption as described previously in impetigo herpetiformis supports the view that this dermatosis of pregnancy is a variant of generalized pustular psoriasis.

1.
Baker H, Ryan TJ: Generalised pustular psoriasis – A clinical and epidemiological study of 104 cases. Br J Dermatol 1968;80:771–793.
2.
Braun-Falco O, Berthold D, Ruzicka T: Psoriasis pustulosa generalisata – Klassifikation, Klinik und Therapie. Hautarzt 1987;38:509– 520.
3.
Holm AL, Goldsmith LA: Impetigo herpetiformis associated with hypocalcemia of congenital rickets. Arch Dermatol 1991;127:91–95.
4.
Lotem M, Katzenelson V, Rotem A, Hod A, Sandbank M: Impetigo herpetiformis: A variant of pustular psoriasis or a separate entity? J Am Acad Dermatol 1989;20:338–341.
5.
Moynihan D, Ruppe JP: Impetigo herpetiformis and hypoparathyroidism. Arch Dermatol 1985;121:1330–1331.
6.
Ott F, Krakowski A, Tur E, Lipitz R, Weisman Y, Brenner S: Impetigo herpetiformis with lowered serum level of vitamin D and its diminished intestinal absorption. Dermatologica 1982;164:360–365.
7.
Oumeish Y, Farraj SE, Bataineh AS: Some aspects of impetigo herpetiformis. Arch Dermatol 1982;118:103–105.
8.
Pierard GE, Pierard-Franchimont C, de la Brassinne M: Impetigo herpetiformis and pustular psoriasis during pregnancy. Am J Dermatopathol 1983;5:215–220.
9.
Camp RDR: Generalized pustular psoriasis of pregnancy; in Champion RH, Burton JL, Ebling FJG (eds): Textbook of Dermatology. London, Blackwell Scientific Publications, 1992, pp 1453–1454.
10.
Selim M, Hegyi V: Pustular eruption of pregnancy treated with locally administered PUVA. Arch Dermatol 1990;126:443–444.
11.
Tada J, Fukushiro S, Fujiwara Y, Kodama H, Nohara N: Two sisters with impetigo herpetiformis. Clin Exp Dermatol 1989;14:82–84.
12.
Thio B, Vermeer BJ: Hypocalcemia in impetigo herpetiformis. A secondary transient phenomenon? Arch Dermatol 1991;127:1587– 1588.
13.
von Hebra F: Über einzelne, während der Schwangerschaft, am Wochenbette und bei Urinalkrankheiten der Frauen zu beobachtende Hautkrankheiten. Wien Med Wochenschr 1872;22:1197–1202.
14.
Winzer M, Wolff HH: Impetigo herpetiformis. Hautarzt 1988;39:110–113.
15.
Braun-Falco O, Plewig G, Wolff HH (eds): Dermatologie und Venerologie. Berlin, Springer, 1995, pp 657–669.
16.
von Zumbusch L: Psoriasis und pustulöses Exanthem. Arch Dermatol Syphilol 1910;99: 1197–1202.
17.
Hönigsmann H, Gschnait F, Konrad K, Wolff K: Photochemotherapy for pustular psoriasis (von Zumbusch). Br J Dermatol 1977;97: 119–126.
18.
Dahl MV: Clinical Immunodermatology, ed 3. St Louis, Mosby, 1996, pp 301–312.
19.
Andersen S, Sjursen W, Laegreid A, Volden G, Johansen B: Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue. Inflammation 1994;18:1–12.
20.
Kuijpers AL, Zeeuwen PL, de Jongh GJ, van de Kerkhof PC, Alemade HA, Schalkwijk J: Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation? Arch Dermatol Res 1996;288:641–647.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.